Related Experiment Video

Updated: Aug 26, 2026

Visualization and Analysis of Blood Flow and Oxygen Consumption in Hepatic Microcirculation: Application to an Acute Hepatitis Model
10:40

Visualization and Analysis of Blood Flow and Oxygen Consumption in Hepatic Microcirculation: Application to an Acute Hepatitis Model

Published on: August 4, 2012

[Cardiovascular function in liver cirrhosis]

K Lenz

    Leber, Magen, Darm
    |April 1, 1987
    PubMed

    Insights

    Patients with cirrhotic liver disease exhibit a hypercirculatory state, characterized by high cardiac output and low systemic vascular resistance. This pattern, driven by vasodilating substances, poses risks during hypovolemia or sepsis due to impaired compensatory mechanisms.

    Area of Science:

    • Cardiovascular Physiology
    • Hepatology
    • Internal Medicine

    Context:

    • Cirrhotic liver disease commonly presents with distinct hemodynamic alterations.
    • Understanding these changes is crucial for managing patient complications.
    • Previous research yielded conflicting results regarding myocardial function.

    Purpose:

    • To elucidate the hemodynamic profile in patients with liver cirrhosis.
    • To investigate the underlying mechanisms of altered vascular resistance.
    • To assess the role of non-hepatic factors in myocardial dysfunction.

    Summary:

    • Patients with liver cirrhosis display a hypercirculatory state with increased cardiac output and reduced systemic vascular resistance.
    • Accumulation of vasodilating substances is the primary driver of decreased vascular resistance.
    • Dysfunction in vasoconstricting systems or sympathetic nervous system interference was not confirmed.
    • Non-hepatic factors are considered potential causes of myocardial dysfunction.

    Impact:

    • Highlights the critical hemodynamic changes in liver cirrhosis.
    • Identifies vasodilating substances as key contributors to vascular resistance.
    • Warns about the catastrophic potential of this state in hypovolemic or septic conditions.
    • Informs clinical management strategies for cirrhotic patients, especially during acute events.

    More Related Videos

    Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats09:37

    Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

    Published on: August 1, 2018

    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease08:41

    Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

    Published on: March 24, 2023

    Related Concept Videos

    Liver Physiology01:30

    Liver Physiology

    The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
    Metabolic Regulation:
    The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
    Cirrhosis I: Introduction01:23

    Cirrhosis I: Introduction

    Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
    Cirrhosis II: Pathophysiology01:24

    Cirrhosis II: Pathophysiology

    Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
    Portal Hypertension01:22

    Portal Hypertension

    Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...